Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy
- 30 September 2004
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 94 (3), 636-642
- https://doi.org/10.1016/j.ygyno.2004.03.012
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Expression of apoptotic regulators and their significance in cervical cancerCancer Letters, 2001
- The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancerEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
- Biologic factors and response to radiotherapy in carcinoma of the cervixInternational Journal of Gynecologic Cancer, 2001
- Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1998
- Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancerBritish Journal of Cancer, 1998
- C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: Immunohistochemical analysis and clinicopathologic correlationHuman Pathology, 1998
- The proto-oncogene Bcl-2 and its role in regulating apoptosisNature Medicine, 1997
- p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases.Journal of Clinical Oncology, 1996
- Apoptosis. Its significance in cancer and cancer TherapyCancer, 1994
- Bcl-2 and the regulation of programmed cell deathThe Journal of cell biology, 1994